TM
ADPT icon

Tiger Management’s Adaptive Biotechnologies ADPT Stock Holding History

Tiger Management’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-589,311
Closed -$8.18M – 15
2022
Q1 		$8.18M Sell
589,311
-526,100
-47% -$8.27M 1.35% 12
2021
Q4 		$31.3M Hold
1,115,411
– – 6.14% 6
2021
Q3 		$37.9M Hold
1,115,411
– – 7.02% 6
2021
Q2 		$45.6M Hold
1,115,411
– – 7.97% 6
2021
Q1 		$44.9M Hold
1,115,411
– – 8.83% 5
2020
Q4 		$66M Hold
1,115,411
– – 14.96% 1
2020
Q3 		$54.2M Hold
1,115,411
– – 15.44% 1
2020
Q2 		$54M Hold
1,115,411
– – 14.89% 1
2020
Q1 		$31M Hold
1,115,411
– – 10.41% 1
2019
Q4 		$33.4M Hold
1,115,411
– – 9.49% 2
2019
Q3 		$34.5M Buy
+1,115,411
New +$45.5M 13.06% 1

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BWLSA
Blue Water Life Science Advisors Larkspur, California $125M AUM 91.82% 1-Year Est. Return

Tiger Management's ADPT Position: Q2 2022 in Review

Tiger Management sold out of Adaptive Biotechnologies (ADPT) in Q2 2022, closing a stake of 589,311 shares — an estimated $8.18M sold.

Tiger Management first reported a position in ADPT in Q3 2019 and held it in 11 quarters. The position peaked at $66M in Q4 2020. 209 funds tracked by Wall St. Rank hold ADPT as of Q2 2022.

  • Tiger Management reported no remaining Adaptive Biotechnologies position as of Q2 2022 after selling out during the quarter.
  • Tiger Management sold 589,311 Adaptive Biotechnologies shares in Q2 2022, an estimated $8.18M.
  • Tiger Management first reported a position in Adaptive Biotechnologies in Q3 2019 and held it in 11 quarters.
  • Tiger Management's Adaptive Biotechnologies position peaked at $66M in Q4 2020.
  • 209 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2022.

Based on Tiger Management's 13F filing for Q2 2022, filed 15 Aug 2022.